- Home
- SYPR vs AKTX Comparison
SYPR vs AKTX Comparison
Compare SYPR & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYPR
- AKTX
- Stock Information
- Founded
- SYPR 1997
- AKTX N/A
- Country
- SYPR United States
- AKTX United States
- Employees
- SYPR N/A
- AKTX N/A
- Industry
- SYPR Industrial Machinery/Components
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- SYPR Industrials
- AKTX Health Care
- Exchange
- SYPR Nasdaq
- AKTX Nasdaq
- Market Cap
- SYPR 44.1M
- AKTX 35.7M
- IPO Year
- SYPR 1994
- AKTX N/A
- Fundamental
- Price
- SYPR $1.92
- AKTX $1.01
- Analyst Decision
- SYPR
- AKTX Strong Buy
- Analyst Count
- SYPR 0
- AKTX 1
- Target Price
- SYPR N/A
- AKTX $5.00
- AVG Volume (30 Days)
- SYPR 31.0K
- AKTX 39.3K
- Earning Date
- SYPR 08-12-2025
- AKTX 08-13-2025
- Dividend Yield
- SYPR N/A
- AKTX N/A
- EPS Growth
- SYPR N/A
- AKTX N/A
- EPS
- SYPR N/A
- AKTX N/A
- Revenue
- SYPR $130,040,000.00
- AKTX N/A
- Revenue This Year
- SYPR N/A
- AKTX N/A
- Revenue Next Year
- SYPR N/A
- AKTX N/A
- P/E Ratio
- SYPR N/A
- AKTX N/A
- Revenue Growth
- SYPR N/A
- AKTX N/A
- 52 Week Low
- SYPR $1.30
- AKTX $0.85
- 52 Week High
- SYPR $3.72
- AKTX $4.22
- Technical
- Relative Strength Index (RSI)
- SYPR 42.86
- AKTX 43.30
- Support Level
- SYPR $1.91
- AKTX $0.94
- Resistance Level
- SYPR $2.03
- AKTX $1.13
- Average True Range (ATR)
- SYPR 0.07
- AKTX 0.06
- MACD
- SYPR -0.00
- AKTX 0.00
- Stochastic Oscillator
- SYPR 26.32
- AKTX 36.79
About SYPR Sypris Solutions Inc.
Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sales of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.